Utilizing humanized HLA-II DR3 and DR4 transgenic mouse models of GAS NF/STSS, here we tested whether skin GAS infection induces neuroimmune changes that could be attenuated by CLN treatment. The gene discussed is TNFRSF10A; the disease is flatulence.